Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

Abstract

The authors conducted a dose-finding study of D-cycloserine, a partial agonist at the glycine site of the N-methyl-D-aspartate subtype of the glutamate receptor, added to conventional neuroleptics for schizophrenic patients with prominent negative symptoms.